The model would adjust Medicare payment for Part B physician-administered drugs based on the lowest prices of that drug in other countries.
The original model was set to roll out at the start of 2021, but was blocked by a U.S. District Court.
CMS received over 1,100 comments on the model, with many agreeing about its mission to combat prescription drug pricing but also expressing concerns over a Jan. 1, 2021, rollout date, according to the document.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.